Vraylar 6 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FK13R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,197
Award facts
- Contract value 100% obligated
- $10,196.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,196.70 to AmerisourceBergen Drug Corp for the supply of Vraylar 6 mg capsules (30-count units) on May 12, 2025, with an ultimate completion date of May 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's comprehensive global pharmaceutical support vehicle for the DLA Medical Supply Chain. Vraylar is a neurological treatment medication supporting military healthcare programs. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical federal vendor supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to meet federal procurement requirements through open competition across a wide spectrum of pharmaceutical products and medical commodities.
Quick answers
Who was awarded contract SPE2DB25FK13R?
SPE2DB25FK13R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 12, 2025.
How much is contract SPE2DB25FK13R worth?
The government has obligated $10,197 on SPE2DB25FK13R.
Is contract SPE2DB25FK13R an order under another contract?
Yes. SPE2DB25FK13R is a delivery order under SPE2DB20D1110, an indefinite delivery contract.
Was contract SPE2DB25FK13R competed?
The extent of competition for SPE2DB25FK13R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award